Chen S-Y, Yu H-T, Kao J-P, Yang C-C, Chiang S-S, Mishchuk DO, et al
What GLP-1 receptor agonists do, in plain terms, is supply pharmacologically the satiety signal the body was not producing effectively enough on its own
Monitoring patient response during the infusion is also important
Finally, we lose bone mass as we age, and our muscles often sag with gravity in our faces - these changes are usually visible further down the aging process, in the late 40s to mid-60s
What did @aaron.endres actually say
[72] used high glucose concentrations to stimulate insulin secretion, cellular glutamate levels increased, but did not correlate with the level of insulin secretion [72]